WO2004022705A3 - Proteines associees a la neurotransmission - Google Patents

Proteines associees a la neurotransmission Download PDF

Info

Publication number
WO2004022705A3
WO2004022705A3 PCT/US2003/027411 US0327411W WO2004022705A3 WO 2004022705 A3 WO2004022705 A3 WO 2004022705A3 US 0327411 W US0327411 W US 0327411W WO 2004022705 A3 WO2004022705 A3 WO 2004022705A3
Authority
WO
WIPO (PCT)
Prior art keywords
ntran
neurotransmission
associated proteins
polynucleotides
agonists
Prior art date
Application number
PCT/US2003/027411
Other languages
English (en)
Other versions
WO2004022705A2 (fr
Inventor
Soo Yeun Lee
Vicki S Elliott
April J A Hafalia
Neil Burford
William W Sprague
Jennifer A Griffin
Yonghong G Yang
Narinder K Chawla
Mariah R Baughn
Shanya D Becha
Reena Khare
Michael B Thornton
Patricia M Mason
Kimberly J Gietzen
Craig H Ison
Joseph P Marquis
Anita Swarnakar
Jayalaxmi Ramkumar
Pei Jin
Thomas W Richardson
Uyen K Tran
Original Assignee
Incyte Corp
Soo Yeun Lee
Vicki S Elliott
April J A Hafalia
Neil Burford
William W Sprague
Jennifer A Griffin
Yonghong G Yang
Narinder K Chawla
Mariah R Baughn
Shanya D Becha
Reena Khare
Michael B Thornton
Patricia M Mason
Kimberly J Gietzen
Craig H Ison
Joseph P Marquis
Anita Swarnakar
Jayalaxmi Ramkumar
Pei Jin
Thomas W Richardson
Uyen K Tran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Soo Yeun Lee, Vicki S Elliott, April J A Hafalia, Neil Burford, William W Sprague, Jennifer A Griffin, Yonghong G Yang, Narinder K Chawla, Mariah R Baughn, Shanya D Becha, Reena Khare, Michael B Thornton, Patricia M Mason, Kimberly J Gietzen, Craig H Ison, Joseph P Marquis, Anita Swarnakar, Jayalaxmi Ramkumar, Pei Jin, Thomas W Richardson, Uyen K Tran filed Critical Incyte Corp
Priority to AU2003270055A priority Critical patent/AU2003270055A1/en
Publication of WO2004022705A2 publication Critical patent/WO2004022705A2/fr
Publication of WO2004022705A3 publication Critical patent/WO2004022705A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne plusieurs modes de réalisation concernant des protéines humaines associées à la neurotransmission (NTRAN) et des polynucléotides qui identifient et codent lesdites protéines. Ces modes de réalisation concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. D'autres modes de réalisation concernent des méthodes de diagnostic, de traitement ou de prévention de troubles associés à l'expression aberrante des NTRAN.
PCT/US2003/027411 2002-09-04 2003-09-02 Proteines associees a la neurotransmission WO2004022705A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003270055A AU2003270055A1 (en) 2002-09-04 2003-09-02 Neurotransmission-associated proteins

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US40838302P 2002-09-04 2002-09-04
US60/408,383 2002-09-04
US40878102P 2002-09-05 2002-09-05
US60/408,781 2002-09-05
US41422102P 2002-09-26 2002-09-26
US60/414,221 2002-09-26
US42648302P 2002-11-13 2002-11-13
US60/426,483 2002-11-13
US43156602P 2002-12-06 2002-12-06
US60/431,566 2002-12-06
US43431702P 2002-12-17 2002-12-17
US60/434,317 2002-12-17
US43776303P 2003-01-03 2003-01-03
US60/437,763 2003-01-03

Publications (2)

Publication Number Publication Date
WO2004022705A2 WO2004022705A2 (fr) 2004-03-18
WO2004022705A3 true WO2004022705A3 (fr) 2006-10-05

Family

ID=31982799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/027411 WO2004022705A2 (fr) 2002-09-04 2003-09-02 Proteines associees a la neurotransmission

Country Status (2)

Country Link
AU (1) AU2003270055A1 (fr)
WO (1) WO2004022705A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005321315A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US8536115B2 (en) 2006-08-31 2013-09-17 Centre For Addiction And Mental Health Compositions and methods for modulating AMPA receptor-mediated excitotoxicity
WO2013102264A1 (fr) * 2012-01-04 2013-07-11 Centre For Addiction And Mental Health Compositions et méthodes de modulation de l'excitoxicité médiée par les récepteurs ampa

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074844A (en) * 1997-06-11 2000-06-13 Incyte Pharmaceuticals, Inc. Polynucleotides encoding human membrane fusion proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074844A (en) * 1997-06-11 2000-06-13 Incyte Pharmaceuticals, Inc. Polynucleotides encoding human membrane fusion proteins

Also Published As

Publication number Publication date
WO2004022705A2 (fr) 2004-03-18
AU2003270055A8 (en) 2004-03-29
AU2003270055A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
WO2003052075A3 (fr) Enzymes
WO2003042357A3 (fr) Enzymes
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2004044165A3 (fr) Proteines associees aux lipides
WO2003068943A3 (fr) Proteines secretees
WO2004048550A3 (fr) Proteines associees a une reponse immune
WO2004053068A3 (fr) Molecules de modification et de maintenance de proteines
WO2004009797A3 (fr) Molecules de modification et d'entretien de proteines
WO2003063688A3 (fr) Molecules de modification et d'entretien de proteines
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2003076586A3 (fr) Proteines associees a des acides nucleiques
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2004003162A3 (fr) Enzymes
WO2003087300A3 (fr) Proteines secretees
WO2003063769A3 (fr) Proteines associees aux vesicules
WO2003072729A3 (fr) Enzymes
WO2003025542A3 (fr) Proteines associees a la reponse immunitaire
WO2003083082A3 (fr) Enzymes
WO2003093439A3 (fr) Enzymes
WO2004022705A3 (fr) Proteines associees a la neurotransmission
WO2004094589A3 (fr) Proteines secretees
WO2003083084A3 (fr) Molecules de modification et d'entretien de proteines
WO2004007527A3 (fr) Proteines secretees
WO2003074726A3 (fr) Proteines associees a une reponse immunitaire
WO2004020593A3 (fr) Proteines associees a la reponse immunitaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP